Phillip A. Sharp - Insider Trading & Ownership

Entity: Individual
Location: Biogen Inc Legal Department, 14 Cambridge Center, Cambridge, MA
Summary: The estimated net worth of Phillip A. Sharp is at least $73.7M dollars as of January 24, 2025. Phillip A. Sharp is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $73.4M. Phillip A. Sharp is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $272K.
All Insider Reports: All Insider Reports

Ownership of Phillip A. Sharp

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Director	$73.4M	-$3.09M	-4.04%	Jan 23, 2025
VIR	Vir Biotechnology, Inc.	Director	$272K			May 22, 2023
SYRS	Syros Pharmaceuticals, Inc.	Director				Jun 1, 2022

Showing 1 to 3 of 3 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.